{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:37:00Z","timestamp":1793813820738,"version":"4.6.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003676"],"award-info":[{"award-number":["82003676"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ijbiomac.2023.126912","type":"journal-article","created":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T11:45:19Z","timestamp":1694864719000},"page":"126912","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"P3","title":["Efficient TNBC immunotherapy by dual reprogramming tumor-infiltrating dendritic cells and tumor-associated macrophages with stimulus-responsive miR155 nanocomplexes"],"prefix":"10.1016","volume":"253","author":[{"given":"Zhenghui","family":"Jing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxiao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlong","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijbiomac.2023.126912_bb0005","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.126912_bb0010","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.126912_bb0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clbc.2021.07.001","article-title":"A systematic comparison of overall survival between men and women with triple negative breast cancer","volume":"22","author":"Yadav","year":"2022","journal-title":"Clinical Breast Cancer"},{"key":"10.1016\/j.ijbiomac.2023.126912_bb0020","first-page":"17","article-title":"Immunotherapy of cancer in the era of checkpoint inhibitor","volume":"39","author":"Hamid","year":"2022","journal-title":"Clin. Exp. Metastasis"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.126912_bb0025","first-page":"13","article-title":"Critical role for CD103(+)\/CD141(+) dendritic cells bearing CCR7 for tumor antigen trafficking and priming of T cell immunity in melanoma","volume":"30","author":"EW","year":"2016","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.126912_bb0030","first-page":"7","article-title":"Tumor-infiltrating dendritic cells in cancer pathogenesis","volume":"194","author":"JM","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.ijbiomac.2023.126912_bb0035","first-page":"9","article-title":"Tumor-associated human dendritic cell subsets-phenotype, functional orientation, and clinical relevance","volume":"0","author":"Plesca","year":"2022","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.ijbiomac.2023.126912_bb0040","first-page":"12","article-title":"Oncolytic adenovirus-mediated intratumoral expression of TRAIL and CD40L enhances immunotherapy by modulating the tumor microenvironment in immunocompetent mouse models","volume":"535","author":"Wenmo Liu","year":"2022","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.126912_bb0045","first-page":"10","article-title":"Dendritic cells induce regulatory t cell proliferation through antigen-dependent and -independent interactions","volume":"185","author":"Tao Zou","year":"2010","journal-title":"The Journal of Immunology"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.126912_bb0050","first-page":"13","article-title":"Targeted delivery of let-7b to reprogramme tumor-associated macrophages and tumor infiltrating dendritic cells for tumor rejection","volume":"90","author":"Huang","year":"2016","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.126912_bb0055","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1021\/acs.molpharmaceut.9b00261","article-title":"Targeted delivery of Zoledronate to tumor-associated macrophages for Cancer immunotherapy","volume":"16","author":"Zang","year":"2019","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.126912_bb0060","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1021\/acs.molpharmaceut.9b00065","article-title":"Targeted delivery of miRNA 155 to tumor associated macrophages for tumor immunotherapy","volume":"16","author":"Zang","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2023.126912_bb0065","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.biomaterials.2021.121137","article-title":"M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages","volume":"278","author":"Gunassekaran","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2023.126912_bb0070","first-page":"11","article-title":"Polymeric nanoparticles promote macrophage reversal from M2 to M1 phenotypes in the tumor microenvironment","volume":"112","author":"Yi Wang","year":"2017","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.126912_bb0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13046-022-02289-2","article-title":"ROR\u03b3t agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers","volume":"41","author":"Xia","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2023.126912_bb0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/jitc-2021-003264","article-title":"The tumor-targeted CD40 agonist CEA-CD40 promotes T cell priming via a dual mode of action by increasing antigen delivery to dendritic cells and enhancing their activation","volume":"10","author":"Sum","year":"2022","journal-title":"Journal for ImmunoTherapy of Cancer"},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.126912_bb0085","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004268","article-title":"Combinations of toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells","volume":"10","author":"He","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.126912_bb0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/jbm.a.37391","article-title":"Supramolecular nanotherapeutics enable metabolic reprogramming of tumor-associated macrophages to inhibit tumor growth","volume":"110","author":"Ramesh","year":"2022","journal-title":"J. Biomed. Mater. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.126912_bb0095","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1038\/s41467-022-30568-1","article-title":"STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer","volume":"13","author":"Wang","year":"2022","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.126912_bb0100","first-page":"9","article-title":"A miR-155-dependent microRNA hierarchy in dendritic cell maturation and macrophage activation","volume":"588","author":"Duecka","year":"2014","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.126912_bb0105","first-page":"1690","article-title":"Repression of arginase-2 expression in dendritic cells by microRNA-155 is critical for promoting t cell proliferation","volume":"193","author":"Dunand-Sauthier","year":"2014"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.126912_bb0110","doi-asserted-by":"crossref","first-page":"1724761","DOI":"10.1080\/2162402X.2020.1724761","article-title":"Overexpression of microRNA-155 enhances the efficacy of dendritic cell vaccine against breast cancer","volume":"9","author":"Hodge","year":"2020","journal-title":"OncoImmunology"},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.126912_bb0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/advs.201802012","article-title":"Synergetic functional nanocomposites enhance immunotherapy in solid tumors by remodeling the immunoenvironment","volume":"6","author":"Yang","year":"2019","journal-title":"Advanced Science"},{"key":"10.1016\/j.ijbiomac.2023.126912_bb0120","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.lfs.2019.01.005","article-title":"Phenotypical and functional evaluation of dendritic cells after exosomal delivery of miRNA-155","volume":"219","author":"Asadirad","year":"2019","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.126912_bb0125","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1158\/0008-5472.CAN-11-3160","article-title":"Reprogramming tumor-associated dendritic cells in vivo using miRNA mimetics triggers protective immunity against ovarian cancer","volume":"72","author":"Cubillos-Ruiz","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2023.126912_bb0130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.biomaterials.2017.04.043","article-title":"Tumor associated macrophage-targeted microRNA delivery with dual-responsive polypeptide nanovectors for anti-cancer therapy","volume":"134","author":"Liu","year":"2017","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.126912_bb0135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13046-022-02244-1","article-title":"Reactive oxygen species reprogram macrophages to suppress antitumor immune response through the exosomal miR-155-5p\/PD-L1 pathway","volume":"41","author":"Li","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.ijbiomac.2023.126912_bb0140","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1021\/mp400216r","article-title":"Targeting of tumor-associated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles","volume":"10","author":"Zhu","year":"2013","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2023.126912_bb0145","doi-asserted-by":"crossref","first-page":"111962","DOI":"10.1016\/j.biopha.2021.111962","article-title":"Mannosylated polylactic-co-glycolic acid (MN-PLGA) nanoparticles induce potent anti-tumor immunity in murine model of breast cancer","volume":"142","author":"Sheikhzadeh","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2023.126912_bb0150","doi-asserted-by":"crossref","first-page":"120711","DOI":"10.1016\/j.biomaterials.2021.120711","article-title":"Enhanced response to PD-L1 silencing by modulation of TME via balancing glucose metabolism and robust co-delivery of siRNA\/resveratrol with dual-responsive polyplexes","volume":"271","author":"Jia","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2023.126912_bb0155","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.biomaterials.2018.01.042","article-title":"Dual-responsive polyplexes with enhanced disassembly and endosomal escape for efficient delivery of siRNA","volume":"162","author":"Zhu","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2023.126912_bb0160","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.actbio.2015.11.041","article-title":"Co-delivery of se nanoparticles and pooled SiRNAs for overcoming drug resistance mediated by P-glycoprotein and class III \u03b2-tubulin in drug-resistant breast cancers","volume":"31","author":"Zheng","year":"2016","journal-title":"Acta Biomater."},{"issue":"43","key":"10.1016\/j.ijbiomac.2023.126912_bb0165","doi-asserted-by":"crossref","first-page":"15344","DOI":"10.1073\/pnas.1411499111","article-title":"Investigating the optimal size of anticancer nanomedicine","volume":"111","author":"Tang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2023.126912_bb0170","doi-asserted-by":"crossref","first-page":"6575","DOI":"10.2147\/IJN.S119033","article-title":"The nasal delivery of nanoencapsulated statins - an approach for brain delivery","volume":"11","author":"Clementino","year":"2016","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2023.126912_bb0175","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jconrel.2021.11.024","article-title":"Engineered strategies to enhance tumor penetration of drug-loaded nanoparticles","volume":"341","author":"Souri","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2023.126912_bb0180","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.actbio.2022.07.022","article-title":"Blockage of the IDO1 pathway by charge-switchable nanoparticles amplifies immunogenic cell death for enhanced cancer immunotherapy","volume":"150","author":"Shi","year":"2022","journal-title":"Acta Biomater."},{"issue":"21","key":"10.1016\/j.ijbiomac.2023.126912_bb0185","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2174\/138161210791920496","article-title":"Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects","volume":"16","author":"Yoo","year":"2010","journal-title":"Current Pharmaceutical Design"},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.126912_bb0190","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/cr.2013.75","article-title":"ROS play a critical role in the differentiation of alternatively activated macrophages and the occurrence of tumor-associated macrophages","volume":"23","author":"Zhang","year":"2013","journal-title":"Cell Res."},{"key":"10.1016\/j.ijbiomac.2023.126912_bb0195","doi-asserted-by":"crossref","first-page":"101416","DOI":"10.1016\/j.nantod.2022.101416","article-title":"Reactivation of dysfunctional dendritic cells by a stress-relieving nanosystem resets anti-tumor immune landscape","volume":"43","author":"Lu","year":"2022","journal-title":"Nano Today"},{"issue":"48","key":"10.1016\/j.ijbiomac.2023.126912_bb0200","doi-asserted-by":"crossref","first-page":"15217","DOI":"10.1021\/jacs.5b09602","article-title":"Tumor acidity-sensitive polymeric vector for active targeted siRNA delivery","volume":"137","author":"Sun","year":"2015","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.126912_bb0205","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1021\/acs.molpharmaceut.0c00160","article-title":"Improved cellular delivery of antisense oligonucleotide for miRNA-21 imaging in vivo using cell-penetrating peptide-based Nanoprobes","volume":"18","author":"Yang","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2023.126912_bb0210","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jconrel.2022.01.012","article-title":"RNA interference (RNAi)-based plasmonic nanomaterials for cancer diagnosis and therapy","volume":"342","author":"Yoon","year":"2022","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.126912_bb0215","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/mt.2012.185","article-title":"The possible \u201cproton sponge \u201d effect of Polyethylenimine (PEI) does not include change in lysosomal pH","volume":"21","author":"Benjaminsen","year":"2013","journal-title":"Mol. Ther."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.126912_bb0220","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1021\/acs.chemmater.9b00167","article-title":"Rational Design of Inflammation-Responsive Inflatable Nanogels for ultrasound molecular imaging","volume":"31","author":"Heo","year":"2019","journal-title":"Chem. Mater."},{"issue":"52","key":"10.1016\/j.ijbiomac.2023.126912_bb0225","doi-asserted-by":"crossref","first-page":"57798","DOI":"10.1021\/acsami.0c19301","article-title":"Specifically eliminating tumor-associated macrophages with an extra- and intracellular stepwise-responsive Nanocarrier for inhibiting metastasis","volume":"12","author":"Guo","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijbiomac.2023.126912_bb0230","doi-asserted-by":"crossref","first-page":"121383","DOI":"10.1016\/j.biomaterials.2022.121383","article-title":"Photothermal-triggered immunogenic nanotherapeutics for optimizing osteosarcoma therapy by synergizing innate and adaptive immunity","volume":"282","author":"Liu","year":"2022","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.126912_bb0235","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1006\/cimm.2001.1883","article-title":"DNA Array and biological characterization of the impact of the maturation status of mouse dendritic cells on their phenotype and antitumor vaccination efficacy","volume":"214","author":"Chen","year":"2001","journal-title":"Cell. Immunol."},{"issue":"18","key":"10.1016\/j.ijbiomac.2023.126912_bb0240","first-page":"21","article-title":"Tumor associated macrophages and TAMs-based anti-tumor nanomedicines","volume":"10","author":"Yuxi Cheng","year":"2021","journal-title":"Advanced Healthcar Materials"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.126912_bb0245","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13046-022-02272-x","article-title":"Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies","volume":"41","author":"Kumari","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2023.126912_bb0250","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2022.8","article-title":"Tumour-associated macrophages heterogeneity drives resistance to clinical therapy","volume":"24","author":"Guo","year":"2022","journal-title":"Expert Rev. Mol. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.126912_bb0255","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1724761","article-title":"Overexpression of microRNA-155 enhances the efficacy of dendritic cell vaccine against breast cancer","volume":"9","author":"Hodge","year":"2020","journal-title":"Oncoimmunology"},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.126912_bb0260","doi-asserted-by":"crossref","first-page":"9731","DOI":"10.1021\/acsnano.5b02471","article-title":"Systemic delivery of anti-miRNA for suppression of triple negative breast Cancer utilizing RNA nanotechnology","volume":"9","author":"Shu","year":"2015","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.126912_bb0265","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.nantod.2016.04.008","article-title":"Surface charge critically affects tumor penetration and therapeutic efficacy of cancer nanomedicines","volume":"11","author":"Wang","year":"2016","journal-title":"Nanotoday"},{"key":"10.1016\/j.ijbiomac.2023.126912_bb0270","doi-asserted-by":"crossref","first-page":"114113","DOI":"10.1016\/j.addr.2022.114113","article-title":"RNAi-based therapeutics and tumor targeted delivery in cancer","volume":"182","author":"Kara","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2023.126912_bb0275","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.8458","article-title":"CD86+\/CD206+ tumor-associated macrophages predict prognosis of patients with intrahepatic cholangiocarcinoma","volume":"8","author":"Sun","year":"2020","journal-title":"PeerJ"},{"key":"10.1016\/j.ijbiomac.2023.126912_bb0280","doi-asserted-by":"crossref","first-page":"107198","DOI":"10.1016\/j.intimp.2020.107198","article-title":"Exosome-mediated miR-33 transfer induces M1 polarization in mouse macrophages and exerts antitumor effect in 4T1 breast cancer cell line","volume":"90","author":"Moradi-Chaleshtori","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.126912_bb0285","first-page":"320","article-title":"CD86+\/CD206+, diametrically polarized tumor-associated macrophages","volume":"17","author":"Dong","year":"2016","journal-title":"Predict Hepatocellular Carcinoma Patient Prognosis"},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.126912_bb0290","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12032-022-01670-7","article-title":"Tumor-associated macrophages of the M1\/M2 phenotype are involved in the regulation of malignant biological behavior of breast cancer cells through the EMT pathway","volume":"39","author":"Chen","year":"2022","journal-title":"Med. Oncol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.126912_bb0295","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12967-022-03444-1","article-title":"Lymphocytes in tumor-draining lymph nodes co-cultured with autologous tumor cells for adoptive cell therapy","volume":"20","author":"Okamura","year":"2022","journal-title":"J. Transl. Med."},{"issue":"615","key":"10.1016\/j.ijbiomac.2023.126912_bb0300","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb6981","article-title":"Macrophage-tumor chimeric exosomes accumulate in lymph node and tumor to activate the immune response and the tumor microenvironment","volume":"13","author":"Wang","year":"2021","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.ijbiomac.2023.126912_bb0305","article-title":"The role of tumor-associated myeloid cells in modulating cancer therapy","volume":"10","author":"Neophytou","year":"2020"},{"key":"10.1016\/j.ijbiomac.2023.126912_bb0310","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bioactmat.2022.03.008","article-title":"Remodeling tumor immunosuppressive microenvironment via a novel bioactive nanovaccines potentiates the efficacy of cancer immunotherapy","volume":"16","author":"Xie","year":"2022","journal-title":"Bioactive Materials"},{"key":"10.1016\/j.ijbiomac.2023.126912_bb0315","article-title":"Oxymatrine and cisplatin synergistically enhance anti-tumor immunity of CD8+ T cells in non-small cell lung cancer","volume":"8","author":"Ye","year":"2018"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023038096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023038096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:41:46Z","timestamp":1758883306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813023038096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":63,"alternative-id":["S0141813023038096"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.126912","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficient TNBC immunotherapy by dual reprogramming tumor-infiltrating dendritic cells and tumor-associated macrophages with stimulus-responsive miR155 nanocomplexes","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.126912","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"126912"}}